Oscar Health (NYSE:OSCR - Get Free Report) was downgraded by equities researchers at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating in a research report issued on Thursday,Briefing.com Automated Import reports. They presently have a $16.00 price target on the stock, down from their prior price target of $20.00. Wells Fargo & Company's price target indicates a potential upside of 12.95% from the company's previous close.
Separately, Jefferies Financial Group initiated coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They issued an "underperform" rating and a $12.00 price objective on the stock. Two investment analysts have rated the stock with a sell rating, three have given a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $20.19.
Check Out Our Latest Report on OSCR
Oscar Health Stock Down 3.3 %
Shares of NYSE:OSCR opened at $14.17 on Thursday. Oscar Health has a 1-year low of $12.43 and a 1-year high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The stock has a market cap of $3.55 billion, a P/E ratio of -707.90 and a beta of 1.75. The firm has a fifty day moving average price of $15.25 and a 200 day moving average price of $16.45.
Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. Sell-side analysts predict that Oscar Health will post 0.69 EPS for the current year.
Hedge Funds Weigh In On Oscar Health
A number of large investors have recently made changes to their positions in the stock. Vanguard Group Inc. grew its position in Oscar Health by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company's stock worth $255,333,000 after buying an additional 586,626 shares during the period. Deerfield Management Company L.P. Series C raised its stake in shares of Oscar Health by 50.7% during the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock worth $159,062,000 after buying an additional 3,983,325 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in Oscar Health by 348.7% during the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock valued at $139,246,000 after acquiring an additional 8,051,379 shares in the last quarter. Thrive Capital Management LLC increased its holdings in Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock valued at $85,258,000 after acquiring an additional 1,588,395 shares in the last quarter. Finally, Gilder Gagnon Howe & Co. LLC raised its position in Oscar Health by 51.4% during the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock worth $85,154,000 after acquiring an additional 2,151,256 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company's stock.
About Oscar Health
(
Get Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
